journal article·2023-09

Design the synthesis of AIEgen photosensitizers for regulating the level of PTX in drug-resistant tumor cells

Huifang Yao, Xiaobo Xiong, Feng Wu, Xiangyang Hu

Dyes and Pigments· Volume 217
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Porphyrin and Phthalocyanine Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (38)

Show source-provided references
1. The role of photodynamic therapy in overcoming cancer drug resistance10.1039/c4pp00495g ↗
2. A multi-action and multi-target ruii–ptiv conjugate combining cancer-activated chemotherapy and photodynamic therapy to overcome drug resistant cancers10.1002/anie.201916400 ↗
3. Drug delivery micelles with efficient near-infrared photosensitizer for combined image-guided photodynamic therapy and chemotherapy of drug-resistant cancer10.1016/j.biomaterials.2019.119330 ↗
4. Mechanisms of resistance to photodynamic therapy10.2174/092986711795843272 ↗
5. The role of photodynamic therapy on multidrug resistant breast cancer10.1186/s12935-019-0815-0 ↗
6. Nanotechnology applied to overcome tumor drug resistance10.1016/j.jconrel.2012.05.051 ↗
7. Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology10.1016/j.jconrel.2011.03.032 ↗
8. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT10.1016/j.jphotobiol.2009.04.001 ↗
9. A review of chemotherapy and photodynamic therapy for lung cancer treatment10.2174/1871520620666200403144945 ↗
10. Overview of nanoparticle-based approaches for the combination of photodynamic therapy (pdt) and chemotherapy at the preclinical stage10.3390/cancers14184462 ↗
11. Advances in nanomaterials for photodynamic therapy applications: status and challenges10.1016/j.biomaterials.2020.119827 ↗
12. Enhanced photodynamic therapy for overcoming tumor hypoxia: from microenvironment regulation to photosensitizer innovation10.1016/j.ccr.2020.213604 ↗
13. Protease-responsive prodrug with aggregation-induced emission probe for controlled drug delivery and drug release tracking in living cells10.1021/acs.analchem.6b02833 ↗
14. Biomacromolecule-functionalized AIEgens for advanced biomedical studies10.1002/smll.201804839 ↗
15. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
16. Photodynamic therapy of cancer — challenges of multidrug resistance
17. Advances in photosensitizer-related design for photodynamic therapy
18. Photosensitizers for photodynamic therapy10.1002/adhm.201900132 ↗
19. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
20. Recent advances in activatable organic photosensitizers for specific photodynamic therapy10.1002/cplu.202000203 ↗
21. Specific light-up bioprobe with aggregation-induced emission and activatable photoactivity for the targeted and image-guided photodynamic ablation of cancer cells10.1002/anie.201408476 ↗
22. A Highly efficient and photostable photosensitizer with near-infrared aggregation-induced emission for image-guided photodynamic anticancer therapy10.1002/adma.201700548 ↗
23. One-step formulation of targeted aggregation-induced emission dots for image-guided photodynamic therapy of cholangiocarcinoma10.1021/acsnano.7b00312 ↗
24. Photosensitizers with aggregation-induced emission: materials and biomedical applications10.1002/adma.201801350 ↗
25. Recent advances in aiegen-based photodynamic therapy and immunotherapy10.1002/adhm.202101066 ↗
26. Highly efficient singlet oxygen generation, two-photon photodynamic therapy and melanoma ablation by rationally designed mitochondria-specific near-infrared AIEgens10.1039/C9SC06441A ↗
27. Recent advances in stimuli-responsive theranostic systems with aggregation-induced emission characteristics10.1002/agt2.10 ↗
28. A high therapeutic efficacy of polymeric prodrug nano-assembly for a combination of photodynamic therapy and chemotherapy10.1038/s42003-018-0204-6 ↗
29. AIEgens for microbial detection and antimicrobial therapy10.1016/j.biomaterials.2020.120598 ↗
30. A novel drug susceptibility testing AIEgen with spatiotemporal resolved progress-reporting characteristic for therapy of drug-resistant tumor10.1016/j.mattod.2022.06.008 ↗
31. Light-responsive AIE nanoparticles with cytosolic drug release to overcome drug resistance in cancer cells10.1039/C6PY00449K ↗
32. An amphiphilic tetraphenylethylene-based photosensitizer for cancer cell ablation and bacteria killing10.1016/j.dyepig.2022.110652 ↗
33. AIE based GSH activatable photosensitizer for imaging-guided photodynamic therapy10.1039/D0CC02045A ↗
34. Tunning intermolecular interaction of peptide-conjugated aiegen in nano-confined space for quantitative detection of tumor marker secreted from cells10.1021/acs.analchem.1c04422 ↗
35. Modular-peptides-based ternary complex for precisely tracking the targeted process and delivery of gene/chemo-drug10.1002/adom.202100966 ↗
36. Tumor-triggered disassembly of a multiple-agent-therapy probe for efficient cellular internalization10.1002/anie.202009196 ↗
37. Multifunctional AIEgens for future theranostics10.1002/smll.201601637 ↗
38. Cancer multidrug resistance10.1038/5289 ↗